Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in ABEO — Abeona Therapeutics Inc.

CIK 1446194 BALA CYNWYD, PA

Position in ABEO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,937,017
-$1,758,770 QoQ
Shares Held
432,370
-38.3% QoQ
Ownership
0.759%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ABEO Over Time

Shares Held

Position Value (USD)

Derivatives in ABEO

reported options exposure · as of Mar 31, 2026
CallValue
$1,309,952
CallShares
292,400
PutValue
$1,719,872
PutShares
383,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,162,367,415 across 355 Biotechnology names. ABEO ranks #109 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ABEO

Export CSV
30 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,309,952 292,400
2026-03-31 $1,719,872 383,900
2026-03-31 $1,937,017 432,370
2025-12-31 $3,695,787 701,288
2025-12-31 $1,106,173 209,900
2025-12-31 $410,533 77,900
2025-09-30 $1,022,736 193,700
2025-09-30 $1,937,760 367,000
2025-06-30 $313,092 55,122
2025-06-30 $681,600 120,000
2025-06-30 $4,711,560 829,500
2025-03-31 $108,052 22,700
2025-03-31 $143,752 30,200
2025-03-31 $3,622,683 761,068
2024-12-31 $110,286 19,800
2024-12-31 $3,220,540 578,194
2024-09-30 $424,956 67,240
2024-09-30 $170,640 27,000
2024-09-30 $372,880 59,000
2024-06-30 $201,667 47,563
2024-06-30 $115,752 27,300
2024-06-30 $74,624 17,600
2024-03-31 $97,875 13,500
2024-03-31 $279,125 38,500
2024-03-31 $199,128 27,466
2023-12-31 $178,356 35,600
2023-12-31 $206,211 41,160
2023-12-31 $153,807 30,700
2023-09-30 $289,972 68,877
2023-09-30 $77,043 18,300